No Data
Longboard Pharmaceuticals Granted Orphan Drug Designation for Bexicaserin
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?
M&A Deals Roundup: Expedia, Sanofi, Zuora, Forward Air and More
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Longboard Pharmaceuticals, Inc. Buyout
Truist Financial Upgrades Longboard Pharmaceuticals(LBPH.US) to Buy Rating, Maintains Target Price $60
H.C. Wainwright Maintains Longboard Pharmaceuticals(LBPH.US) With Buy Rating, Cuts Target Price to $60
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
101715680 : Give 20 days sure drop
10percents OP : why this is not moving up?